Clinical Trial Update: The Use of VSL#3 in Irritable Bowel Syndrome in Children [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the probiotic VSL#3 in children with irritable bowel syndrome was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• VSL#3

Snippet

Sponsor: Dayton Children's Hospital | Conditions: Irritable Bowel Syndrome | Phase 1 | Status: TERMINATED